MedicalDevice Licensing.com
Pharmalicensing.com
Latest: Watch here for details of new products and services.
RSS Feeds
Advanced search

Login  Register

About Us
Pharmalicensing - Partnering solutions for the life sciences
 
Our Products
Overview
Partnering Search
Company Profiling
Deal Negotiation
PL Intelligence
Reports
Comparison
 
PL Intelligence
Overview
Industry news
Deals review
Press releases
Articles
 
Case Studies
See what others think about our service
 
Newsletter
Partnering update
Key reports
Subscribe
 
Quick Links
Profile now
Register now
Profiled companies
Featured events
Industry news
PR Newswire
Jobs
 
Contact Pharmalicensing
Send an email
Call us: +44 1904 520460
Request a callback
 
RSS Feeds
Keep up to date

Pharmalicensing
is a division of
UTEK Europe Ltd
UTEK Corporation
PR Newswire

News of the day

Menicon to Acquire David Thomas Contact Lenses Ltd., Major U.K. Custom Lens Manufacturer

19th November 2009 NAGOYA, Japan, November 19 /PRNewswire/ -- Menicon Co., Ltd. (Menicon) and David Thomas Contact Lenses Ltd. (DTCL) announced on November 19 that the two companies reached agreement on November 16, 2009 for Menicon to acquire 100% of the ownership of DTCL. The acquisition of DTCL will enable Menicon to build on DTCL's successful business in the U.K. and abroad. Menicon has an important presence in the European rigid gas permeable (RGP) lens and lens care market, though not in the U.K. The... more

Novartis to Acquire Majority Stake in Hard to Treat Diseases' (HTDS.PK) China Subsidiary H1N1 Vaccine Partner for US$125 Million

9th November 2009 SHENZHEN, China, November 9 /PRNewswire/ -- Hard To Treat Diseases (OTC: HTDS) http://www.htdsmedical.com, announced today that Novartis, a US$41 billion international healthcare company, is acquiring an 85% stake in HTDS' H1N1 Vaccine partner, Zhejiang Tianyuan Bio-Pharmaceutical Co., Ltd., for US$125 million. Novartis of Switzerland will begin a five-year, $1 billion China initiative with two aims: the company will dramatically increase its investment in its China R&D facility, and it will... more

Warner Chilcott Completes Acquisition of P&G's Global Branded Prescription Pharmaceuticals Business

30th October 2009 ARDEE, Ireland, October 30 /PRNewswire/ -- Warner Chilcott plc (Nasdaq: WCRX) announced today it has completed the acquisition of The Procter & Gamble Company's global branded prescription pharmaceutical business. The acquisition complements Warner Chilcott's existing presence in women's health care and adds new therapeutic and geographic markets. At closing approximately 1,900 employees of P&G's pharmaceuticals business joined Warner Chilcott and the Company added manufacturing facilities in... more
Acquisitions, Mergers and Takeovers RSS feed

PR Newswire search

Search the PR Newswire by keyword. Alternatively our advanced search allows you to query by category.
 

Category

To choose more then one item on the list hold CTRL button while selecting. To deselect items press CTRL button and deselect.

Browse by category

More recent news

Cell Biosciences Completes Acquisition of Alpha Innotech
28th October 2009 SANTA CLARA, California, October 28 /PRNewswire/ -- Cell Biosciences, Inc. today announced that it has completed its acquisition of Alpha Innotech Corp. (OTC Bulletin Board: APNO). The stockholders...

eBioscience Acquires Bender MedSystems; Business Combination Adds Cutting-Edge Product Lines and Expands International Operations
27th October 2009 SAN DIEGO and VIENNA, October 27 /PRNewswire/ -- eBioscience Corporation today announced that it has acquired privately held immunoassay technology pioneer Bender MedSystems GmbH in an all...

Potentia Pharmaceuticals Enters into Licensing and Purchase Option Agreements with Alcon
23rd October 2009 LOUISVILLE, Kentucky, October 23 /PRNewswire/ -- -- Alcon takes over development of POT-4 as a treatment for patients with age-related macular degeneration -- Deal provides path for Alcon to...

Essilor - 2009 Third Quarter Report
22nd October 2009 CHARENTON-LE-PONT, France, October 22 /PRNewswire/ -- Essilor International, the world leader in ophthalmic optics, today announced its consolidated revenue for the nine months ended September 30,...

Czura Thornton Announces Intention to Acquire Global Central Laboratory Business of MDS Pharma Services
9th October 2009 LONDON, October 9 /PRNewswire/ -- Private investment firm Czura Thornton today announced it has signed an agreement to acquire the global central laboratory ('GCL') operations of MDS Pharma Services,...

ResMed Acquires Laboratoires Narval
5th October 2009 SAN DIEGO, October 5 /PRNewswire/ -- ResMed Inc. (NYSE: RMD), a leading developer, manufacturer and distributor of sleep and respiratory medical equipment, announced today that it has acquired...

Hospira Acquires Worldwide Rights to Biogeneric Version of Filgrastim and Manufacturing Facility From PLIVA
30th September 2009 LAKE FOREST, Illinois, September 30 /PRNewswire/ -- -- Expands Biologics Manufacturing/Commercial Capabilities -- Hospira, Inc. (NYSE: HSP), a global specialty pharmaceutical and medication...

Raptor Pharmaceuticals Corp. and TorreyPines Complete Merger
30th September 2009 NOVATO, California, September 30 /PRNewswire/ -- Raptor Pharmaceuticals Corp. ("Raptor") (OTC Bulletin Board: RPTP) and TorreyPines Therapeutics, Inc. ("TorreyPines") (Nasdaq: TPTX) announced...

Raptor Pharmaceuticals and TorreyPines Therapeutics Receive Stockholder Approvals to Merge
28th September 2009 NOVATO, California, September 28 /PRNewswire/ -- Raptor Pharmaceuticals Corp. ("Raptor" or the "Company") (OTC Bulletin Board: RPTP), today announced that its stockholders approved the proposals...

Abbott to Acquire Solvay Pharmaceuticals Business
28th September 2009 ABBOTT PARK, Illinois, September 28 /PRNewswire/ -- Abbott today announced a definitive agreement with the Solvay Group for Abbott to acquire Solvay's pharmaceuticals business for EUR 4.5...

New Collaborations and Breakthrough Advancements in RNA-Based Drug Development Programs Lead Santaris Pharma A/S to Establish US Operations
16th September 2009 HOERSHOLM, Denmark and SAN DIEGO, California, September 16 /PRNewswire/ -- Santaris Pharma A/S, a privately-held biopharmaceutical company focused on developing RNA-based drugs targeted to...

Fountain Healthy Aging Inc Announces Agreement to Acquire Natural Planet USA
14th September 2009 LOS ANGELES, September 14 /PRNewswire/ -- Fountain Healthy Aging Inc. announced on September 14 2009 that it had entered into an agreement to acquire the entire issued stock of Natural Planet USA...

Cell Biosciences Signs Agreement to Acquire Alpha Innotech
8th September 2009 SANTA CLARA, California, September 8 /PRNewswire/ -- Cell Biosciences, Inc. and Alpha Innotech Corp. (OTC Bulletin Board: APNO) today announced that they have entered into a definitive...

Partnership Between Celesio and Panfarma Sealed
31st August 2009 VITORIA, Brazil, August 31 /PRNewswire/ -- Yesterday, on Sunday 30 August, the partnership between Celesio and Panfarma was sealed in a joint communiqué in the presence of the German and the...

Raptor Pharmaceuticals Raises US$5 Million
25th August 2009 NOVATO, California, August 25 /PRNewswire/ -- Raptor Pharmaceuticals Corp. ("Raptor" or the "Company") (OTC Bulletin Board: RPTP), today announced that it has raised an aggregate US$5 million...

Raptor Pharmaceuticals Corp. and TorreyPines Therapeutics, Inc. Announce Merger Agreement
28th July 2009 NOVATO, California and LA JOLLA, California, July 28 /PRNewswire/ -- Raptor Pharmaceuticals Corp. ("Raptor" or the "Company") (OTC Bulletin Board: RPTP) and TorreyPines Therapeutics, Inc....

Celesio Acquires Majority Stake in Number One Brazilian Pharmaceutical Wholesaler Panpharma
10th July 2009 STUTTGART, Germany, July 10 /PRNewswire/ -- The supervisory board of Celesio AG has today approved the majority holding of 50.1 per cent in pharmaceutical wholesaler Panpharma. This step into one...

Clients in focus...

Get the Flash Player to see this rotator.

Partnering and licensing intelligence in life sciences industry
BioTrinity
Press releases: Pharmalicensing current industry press releases.

© Copyright 1995-2009 Pharmalicensing, a division of UTEK Europe Ltd UTEK Corporation All rights reserved. Terms and Conditions | Contact us